The Big Picture: Whole Body MRI STIR and its uses in a ... · thickening - possible melorheostosis...
Transcript of The Big Picture: Whole Body MRI STIR and its uses in a ... · thickening - possible melorheostosis...
![Page 1: The Big Picture: Whole Body MRI STIR and its uses in a ... · thickening - possible melorheostosis Table 3 Age of patient Did the patient have GA during WBMS? % (No.) Indication to](https://reader035.fdocuments.in/reader035/viewer/2022063002/5f47aa330698dd2763060bed/html5/thumbnails/1.jpg)
TheBigPicture:WholeBodyMRISTIRanditsusesinatertiarypaediatrichospitalDrRPrasad1,DrPMenon2,DrHChaudhry2,DrCLandes2,DrSHarave2.
AlderHeyChildren’sHospitalNHSTrust,Liverpool,UK.Abstract
Purpose:Anecdotallyinourcentre,wholebodyMRISTIR(WBMS)isbecomingthepreferredimagingmodalityinassessingsystemicdiseaseinchildren,replacingtheolderimagingmodality,bonescan.Therearenocurrentguidelinesinthisarea.TheauthorsaimtoreviewtheuseofWBMS,andcomparethefindingswithtraditionalbonescans.
Methods:ThiswasaretrospectivestudyinwhichdatawascollectedaboutWBMSperformedinourcentrefrom2011-2016. WecomparedthefindingsofWBMSwithbonescanfindingsinthepatientsthathadundergoneboth.
Results: 126WBMRISTIRscanswereincludedinthestudy.Theaveragepatientagewas9years.Most(66%)patientsdidnotrequireGA.Most requestswerefortheinvestigationofrheumatological,infectiousandoncologicaldisease.Most(63%)ofthescanshadpositivefindings.20patientsunderwentabonescanwithin6weeksoftheWBMS.15ofthesehadconcurringfindingsonbothscans.Intheremaining5caseswithdiscrepantfindings,nonewereclinicallysignificant.
Conclusion:Ourstudydemonstratesthatinourpractice,mostfindingsonWBMSandbonescanareconcurring.TherewasnothingclinicallysignificantmissedInthecasesinwhichtherewerediscrepantfindings.TheauthorsproposethatWBMSisaveryusefulandeffectiveimagingmodalityforimagingmulti-focaldiseaseinchildren.Withouttheuseofionisingradiation,itsallowstheassessmentofbothosteoblasticandosteoclasticskeletalandextra- skeletallesions.FurtherrobuststudiesareneededtoinformguidelinesontheroleofWBMSinthepaediatricsetting.
Background
Traditionally,nuclearmedicinescanssuchasbonescanswerethemainstayofimagingformulti-focaldiseaseinchildren.Howeversincearound2000,advancesinMRtechnologyandsoftwarehavemadewholebodyMRSTIR(WBMS)imagingpossible1,2.STIRisaT2fatsuppressedsequence,resultinginwater-containingstructuresdemonstratinghighsignal.Thisisusefulasmostpathologicallesionscontainwater.SeeTable1fortheadvantagesanddisadvantagesofWBMS.
ResultsOutofatotal138WBMSscansperformedbetween2011-2016,126wereincluded.
Meanageofpatient:9yearsold(youngest6wks,oldest18yrs)%ofpatientsthatdidnotrequireGA:Atleast66%(83)(Yes14%(18),Unknown20%(25))Scanindication:34%(43)oncology,30%(38)rheumatology,24%(31)infection,11% (14)miscellaneous(Piechart1showsthetypesofpathologies)FindingsonWBMS:63%withsignificantfinding,32%nofindings,6%incidentalfindings(ovariancysts,non-pathologicalnodes,traceoffluid)20patientshadabonescanwithin6weeksoftheirWBMS,theresultsareshowninTable4.
StudyaimsTheuseofwholebodyMRISTIR(WBMS)inmulti-focaldiseasepaediatricdiseaseisanecdotallyincreasingtobecomethepreferredimagingmodalityovertraditionalbonescans.Intheabsenceofguidelines,theauthorsaimto:1. FormallyreviewouruseofWBMS2. ComparethefindingsofWBMSwiththefindingson
bonescans.
MethodsTable2showstheinclusionandexclusioncriteria.3radiologyregistrarscollecteddata,showninTable3,usinginformationfoundonPACS.
Discussion:Ourstudywaslimitedasitwasretrospective,andwehadarelativelysmallnumberofpatientswhohadundergonebothWBMSandbonescaninthesameclinicalpresentation.Howevertheauthorsfeelourstudydemonstratesthatinourpractice,mostfindingsonWBMSandbonescanareconcurring.TherewasnothingclinicallysignificantmissedbyeithermodalityInthecasesinwhichtherewerediscrepantfindings.TheauthorsproposethatWBMSisaveryusefulandeffectiveimagingmodalityforimagingmulti-focaldiseaseinchildren.Withouttheuseofionisingradiation,itallowstheassessmentofbothosteoblasticandosteoclasticskeletalandextra- skeletallesions.ItdoeshoweveraddtothepressuresontheMRscanner,andpoorspecificitymayleadtofalsepositives.Somecentresadddiffusionweightedand/orT1sequencestoWBMStoreducefalsepositives,thoughscantimeislengthened.Furtherrobuststudiesareneededtoinformevidence-basedguidelinesontheroleofWBMSinthepaediatricsetting.
Table4:Outofthe 20patientswhounderwentbothWBMSandbonescanswithin6weeks,15 hadthesamefindingsonbothscans.Thefollowing5caseshaddiscrepantfindings.Case 1indication :Toddlerwithtreatedmetastatic rhabdomyosarcomaWBMS: High STIRsignalintheproximallefttibiawhichcouldbenewmetastasis(Fig.1a),BONESCAN(sameday):nocorrespondinghighsignalintheleftproximaltibia,overallincreaseduptakeintheleftlegduetoincreaseduse(Fig.1b)OUTCOME:followupx-rayshowedscleroticmetaphyses(Fig.1c)- felttobeinkeepingwithbenignradiotherapychanges.
Case2indication:Teenagerwithpreviouslyresectedspinaltumourabroad,baselineimagingneeded.WBMS:Highsignalinrightiliacwingwhichcouldbenewmetastasis(Fig.2a).BONESCAN(6weeksprior):normal(Fig.2b)OUTCOME:followupWBMS6monthslaterwasnormal(Fig.2c)– initialWBMSfindingwasfelttohavebeenartefactual.
Case3indication :TeenagerwithrelapsedEwing’stumour(Fig.3a)BONE SCAN: Ewing’stumourinthedistalleftfemur.Twohotspotsabovetherightiliaccrest(Fig.3b),couldbenewmetastases.WBMS(sameday):(Fig.3c)Nometastasis.OUTCOME:On balancebonescanfindingwasfelttobeanartefactualfinding.
Case4indication:TeenagerwithmultiplejointpainsandswellingBONESCAN:uptakeinrightindexfinger- dactylitis(Fig.4a),WBMS (2weekslater):normal(Fig.4b)OUTCOME:DactylitishadprobablyresolvedbythetimetheWBMSwasperformed.
Case5indication: Teenagerwithjuvenile idiopathicarthritispresentingwithlegpainsBONESCAN:bilateraltibialshaftuptakewhichcouldbeshinsplints(Fig.5a)WBMS (sameday):normal(Fig.5b)OUTCOME:X-ray6monthslater(Fig.5c)foundsubtlediffusecorticalthickening- possiblemelorheostosis
Table3
AgeofpatientDidthepatienthaveGAduringWBMS?%(No.)
IndicationtodoWBMS%(No.)
Findings onWBMS(%)
No. ofpatientswhoalsohad
bonescaninthesameepisode
WBMSandbonescanfindings
Table1WBMS advantagesoverbonescan WBMSdisadvantages
- Noionisingradiation.Bonescans caninvolveupto4.4mSV.1- TheliteraturesuggeststhatMRISTIRismoresensitiveatdetectinglesionsthanbonescans.1,2
- Detectsbothosteoblasticandosteoclasticskeletalandextra-skeletallesions. Bonescansonlydetectskeletalosteoblasticlesions.
- Takeslesstime.WBMS isa15minutescanvs >4hrstotaltimeneededforabonescanappointment(radio-isotopeisinjected4hourspriortothescan)
- Poorspecificityforpathologicallesionsandsusceptibletoartifact.Benignlesionscanmay alsodemonstratehighsignalonWBMS3- Youngerpatientsrequiregeneralanaesthetic(usually4m- 4yrolds,similarbonescans)- Noisyandclaustrophobic- IncreasestheburdenofdemandoftheMRslots.
Table2InclusionCriteria ExclusionCriteria
-WBMS onAlderHeyPACS(studycodeMSKES)-Performedbetween2011-December2016
- IfothersequencesbesidesSTIRwereused- Iftheradiologyreportwasunavailable(usuallybecausescanwasfromanothertrust)
- Ifitwasdoneasapost-mortemscan.
References
1.MentzelHJ,KentoucheK,SaunerD,etal.Comparisonofwhole-bodySTIR-MRIand99mTcmethylene-diphosphonatescintigraphyinchildrenwithsuspectedmultifocalbonelesions. EurRadiol. 2004;14:2297–2302.doi:10.1007/s00330-004-2390-5.2.Whole-BodyMRImagingforDetectionofBoneMetastasesinChildrenandYoungAdul,HeikeE.Daldrup-Link, ChristianeFranzius, ThomasM.Link, DanielaLaukamp, JoachimSciuk, HeribertJürgens, OtmarSchober,and ErnstJ.Rummeny,AmericanJournalofRoentgenology 2001 177:1, 229-2363.FastSTIRWhole-BodyMRImaginginChildren,ChristianJ.Kellenberger, MonicaEpelman, StephenF.Miller,and PaulS.Babyn,RadioGraphics 2004 24:5, 1317-13304.SmetsAM,DeurlooEE,SlagerTJE,StokerJ,BipatS.Whole-bodymagneticresonanceimagingfordetectionofskeletalmetastasesinchildrenandyoungpeoplewithprimarysolidtumors- systematicreview. PediatricRadiology.2018;48(2):241-252.doi:10.1007/s00247-017-4013-8.
Oncology 34%(43)
Rheumatology =30%(38)
Infection24%(31)
11%Miscellaneous• Hemihypertrophy• Complexidiopathicosteolytic
syndrome,• LCH
• 30%Rhuematology• DiagnosisorfollowupofJIA,• SAPHO• Jointpain/jointswelling• Sarcoidosis, Vasculitis
• 24%Infection:• DiagnosisandfollowupofCRMO• Diagnosisandfollowupofosteomyelitis• Pyrexiaofunknownorigin
• 34%Oncology• Bonytumours,softtissuetumours,
neuroblastoma,rhabdomyosarcoma(diagnosis,stagingandfollow–up)
PIECHART1
Fig.1b Fig.1c
Fig.2a Fig.2b Fig.2c
Fig.3a
Fig.1a
Fig3b Fig.3c
Fig.4a Fig.4b
Fig.5a Fig.5b Fig.5c